by Angela C. H. McDonald | Nov 16, 2011
The stem cell community was shocked to hear Geron Corporation’s announcement on Monday that the company will immediately discontinue its stem cell programs including its much-publicized Phase I clinical trial for the treatment of spinal cord injury. Following a...
by Lisa Willemse | Nov 15, 2011
Art shows are not exactly routine activities for those who work in research, let alone in the field of stem cells. So when an art exhibit that examines our perceptions of biotechnology and stem cell research opens in New York, it’s something of an occasion. Even...
by Lisa Willemse | Nov 8, 2011
Last week, Statistics Canada released a report with figures detailing the cause of death in which it noted that, for the first time, cancer had eclipsed heart disease as the leading cause of death in every province and territory in the country. According to the...
by Angela C. H. McDonald | Nov 3, 2011
In the body, cells receive instructive signals from their niche, but how do researchers direct stem cells to perform a specific function? Researchers supply cues to cells in the form of growth factors, small molecules, cell culture density, culture surface and...
by Ubaka Ogbogu | Oct 20, 2011
The Court of Justice of the European Union (ECJ) ruled this week that scientific research patents cannot be granted for human embryonic stem cell products under European Union (EU) law. The patent in issue, held by Dr. Oliver Brüstle, Director of the Institute of...
by Stem Cell Network | Oct 14, 2011
Every year at the World Stem Cell Summit, the Genetics Policy Institute (GPI) hands out a number of Stem Cell Action Awards to recognize organizations and individuals who have positively impacted the stem cell community. This year in Pasadena, California, GPI awarded...
Comments